Detalhe da pesquisa
1.
Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population.
Eur J Cancer;
190: 112947, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451182
2.
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD.
Pharmacoepidemiol Drug Saf;
32(10): 1161-1177, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309816
3.
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol;
34(4): 339-357, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872130
4.
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol;
34(4): 358-376, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669645
5.
Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches.
Ann Oncol;
33(9): 893-908, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777706
6.
Malignant pleural mesothelioma: new guidelines make us stronger for defeating this disease.
Ann Oncol;
33(2): 123-125, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883215
7.
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upâ.
Ann Oncol;
32(7): 839-853, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864941
8.
Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy.
Lung Cancer;
155: 163-169, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838467
9.
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.
Respir Med Res;
78: 100788, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32980653
10.
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry.
Lung Cancer;
140: 107-112, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31911323
11.
Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?
Cancer Treat Rev;
71: 47-58, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359792
12.
Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer.
Lung Cancer;
121: 76-81, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858031
13.
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Eur J Cancer;
51(17): 2534-44, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26323530
14.
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
Lung Cancer;
84(1): 86-91, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529684
15.
Lung cancer in idiopathic pulmonary fibrosis patients diagnosed during or after lung transplantation.
Respir Med Case Rep;
5: 37-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-26029585
16.
Hyperthyroidism caused by excessive consumption of sausages.
Neth J Med;
68(3): 135-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20308711